Changes in the Workforce Characteristics of Providers Who Care for Adult Patients With Rheumatologic and Musculoskeletal Disease in the United States

Documenti analoghi

• Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis
  di: Giovanni Adami, et al.
  Pubblicazione: (2025)
• J. Claude Bennett, MD, 1933–2024
  di: S. Louis Bridges, et al.
  Pubblicazione: (2024)
• Fine particulate matter constituents, ozone, and systemic lupus erythematosus: A large general‐population cohort analysis with extended quantile g‐computation
  di: Naizhuo Zhao, et al.
  Pubblicazione: (2026)
• Where We Live Matters: Varied Disease Burden and Treatment Patterns in Psoriatic Arthritis in the United States
  di: Brittany Banbury, et al.
  Pubblicazione: (2026)
• Trends in New Use of Disease‐Modifying Antirheumatic Drugs for Juvenile Idiopathic Arthritis Among Commercially Insured Children in the United States from 2001 to 2022
  di: Priyanka Yalamanchili, et al.
  Pubblicazione: (2024)